NCT03886220 2022-03-31A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenAbbViePhase 4 Completed82 enrolled 10 charts